pharmaxolol eye drops
betaxolol hydrochloride - eye drops - 0.5%w/v - betaxolol
trusamide dorzolamide (as hydrochloride) 20 mg/ml eye drops bottle
viatris pty ltd - dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops - excipient ingredients: water for injections; benzalkonium chloride; hyetellose; mannitol; sodium citrate dihydrate; sodium hydroxide - trusamide eye drops are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
iopidine apraclonidine 5mg/ml (as hydrochloride) eye drops bottle
clinect pty ltd - apraclonidine hydrochloride, quantity: 5.75 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; sodium acetate; sodium chloride; hydrochloric acid; sodium hydroxide; purified water - to control intraocular pressure in glaucoma patients on maximally tolerated glaucoma therapy for a period of 3 months. in clinical studies the drop in intraocular pressure (iop) appeared to decrease after day 60 which may be associated with a progression of the disease or loss of effect of the drug. this phenomenon appears to be an individual occurence with a variable time of onset. as with any patient on maximally tolerated therapy (see dosage & administration), patients using apraclonidine 0.5% eye drops to delay surgery should have frequent follow-up examinations and treatment should be discontinued if iop rises significantly. in patients who have maintained a response to apraclonidine 0.5% eye drops for 3 months and a decision is made to continue treatment, safety aspects, including any evidence of corneal changes (see warnings and precautions), and iop control should be closely monitored.
betac 20mg tablets
komedic sdn bhd - betaxolol hcl -
betoptic s sterile ophthalmic suspension 0.25%
novartis (singapore) pte ltd - betaxolol hcl eqv betaxolol - solution - 0.25% w/v - betaxolol hcl eqv betaxolol 0.25% w/v
betoptic sterile ophthalmic solution 0.5%
novartis (singapore) pte ltd - betaxolol hcl 0.56% w/v eqv betaxolol - solution - 5.6 mg/ml - betaxolol hcl 0.56% w/v eqv betaxolol 0.5% w/v
betoptic 0.25% eyedrops 0.25 %w/v eye drops suspension
alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v
betoptic 5.6mg/ ml (equivalent to betaxolol base 5mg/ ml) sterile ophthalmic solution
alcon laboratories (phils.), inc. - betaxolol (as hydrochloride) - sterile ophthalmic solution - 5.6mg/ ml (equivalent to betaxolol base 5mg/ ml)
betoptic
novartis south africa (pty) ltd - betaxolol hydrochloride - opthalmic solution - betaxolol 5 mg/ml
dorzolamide hydrochloride ophthalmic solution
bausch & lomb inc - dorzolamide (dorzolamide hydrochloride) - solution - 20mg - dorzolamide (dorzolamide hydrochloride) 20mg - carbonic anhydrase inhibitors